Company Filing History:
Years Active: 2017-2019
Title: Suguru Dohi: Innovator in Pharmaceutical Chemistry
Introduction
Suguru Dohi is a notable inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit androgen activity and treat tumors. With a total of 3 patents to his name, Dohi's work is recognized for its potential impact on medical treatments.
Latest Patents
Dohi's latest patents include a tetrahydropyridopyrimidine compound or salt thereof, which outlines a method for inhibiting androgen activity. This involves administering an effective amount of the compound to a subject in need. Additionally, he has developed a method for treating tumors using the same tetrahydropyridopyrimidine compound, showcasing his focus on addressing critical health issues.
Career Highlights
Suguru Dohi is currently associated with Taiho Pharmaceutical Company Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science and improving patient outcomes through targeted therapies.
Collaborations
Dohi has collaborated with esteemed colleagues such as Kazuhisa Minamiguchi and Shigeo Okajima. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Suguru Dohi's contributions to pharmaceutical chemistry are significant, with a focus on developing innovative treatments for androgen-related conditions and tumors. His work exemplifies the importance of research and collaboration in advancing medical science.